111 (YI) Total Current Liabilities (2017 - 2025)
111's (YI) quarterly Total Current Liabilities came in at $275.5 million in Q4 2025, down 15.54% year-on-year from $326.1 million in Q4 2024, and down 11.93% quarter-over-quarter from $312.8 million in Q3 2025.
111 (YI) Total Current Liabilities (2017 - 2025) Analysis & Trends
111 has disclosed Total Current Liabilities across 9 years of filings, most recently posting $275.5 million for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $275.5 million, down 15.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $275.5 million (down 15.54% YoY), and the FY2025 annual result was $279.4 million, down 12.95% from the prior year.
- Total Current Liabilities came in at $275.5 million for Q4 2025 at 111, down from $312.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $364.2 billion in Q1 2023 to a low of $266.7 million in Q1 2021.
- The 5-year median for Total Current Liabilities is $341.1 million (2024), against an average of $68.4 billion.
- Across the five-year window, Total Current Liabilities jumped 121205.68% in 2021 and plunged 99.9% in 2024, its largest moves.
- 111's Total Current Liabilities stood at $333.1 million in 2021, then increased by 15.01% to $383.2 million in 2022, then dropped by 0.5% to $381.3 million in 2023, then retreated by 14.46% to $326.1 million in 2024, then slipped by 15.54% to $275.5 million in 2025.
- The last three Total Current Liabilities figures came in at $275.5 million (Q4 2025), $312.8 million (Q3 2025), and $293.4 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 12.02 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 67.02 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 56.13 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 41.99 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 3.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 1.20 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.51 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 275.45 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 34.08 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 275.45 Mn |
| Sep 30, 2025 | 312.78 Mn |
| Jun 30, 2025 | 293.43 Bn |
| Mar 31, 2025 | 299.68 Mn |
| Dec 31, 2024 | 326.12 Mn |
| Sep 30, 2024 | 377.60 Mn |
| Jun 30, 2024 | 341.08 Mn |
| Mar 31, 2024 | 357.94 Mn |
| Dec 31, 2023 | 381.25 Mn |
| Sep 30, 2023 | 408.57 Mn |
| Jun 30, 2023 | 320.06 Bn |
| Mar 31, 2023 | 364.23 Bn |
| Dec 31, 2022 | 383.16 Mn |
| Sep 30, 2022 | 317.44 Mn |
| Jun 30, 2022 | 335.61 Mn |
| Dec 31, 2021 | 333.15 Mn |
| Sep 30, 2021 | 316.09 Bn |
| Jun 30, 2021 | 321.37 Mn |
| Mar 31, 2021 | 266.74 Mn |
| Dec 31, 2020 | 245.91 Mn |